Revised. Amendments from Version 1
==================================

In the revised manuscript, we have added new data that support our conclusions. Specifically, our RT-PCR reveals that a human liver cancer cell line displays similar gene expression profile during anastasis as observed in mouse primary liver cells. Additional microarray statistical analysis is included as supplementary data. We have also discussed the potential molecular mechanisms, physiological and pathological consequences, and therapeutic potentials of anastasis.

Introduction
============

Apoptosis (Greek for "falling to death") is essential for normal development and homeostasis of multicellular organisms by eliminating unwanted, injured, or dangerous cells ^[@ref-1]--\ [@ref-3]^. This cell suicide process was generally assumed to be irreversible because it involves rapid and massive cell destruction ^[@ref-4]--\ [@ref-9]^. During apoptosis, intrinsic and extrinsic pro-apoptotic signals can converge at mitochondria, leading to mitochondrial outer membrane permeabilization (MOMP), which releases cell execution factors, such as cytochrome *c* to trigger activation of apoptotic proteases including caspase-3 and -7 ^[@ref-10],\ [@ref-11]^, small mitochondria-derived activator of caspases (Smac)/direct IAP binding protein with low pI (DIABLO) to eliminate inhibitor of apoptosis protein (IAP) which suppresses caspase activation ^[@ref-12],\ [@ref-13]^, and apoptosis-inducing factor (AIF) and endonuclease G to destroy DNA ^[@ref-14]--\ [@ref-17]^. Activated caspases commit cells to destruction by cleaving hundreds of functional and structural cellular substrates ^[@ref-4],\ [@ref-18]^. Crosstalk between signalling pathways amplifies the caspase cascade to mediate cell demolition via nucleases (DNA fragmentation factor \[DFF\]/caspase-activated DNase \[CAD\]) to further destroy the genome ^[@ref-19]--\ [@ref-21]^, and alter lipid modifying enzymes to cause membrane blebbing and apoptotic body formation ^[@ref-22],\ [@ref-23]^. Therefore, cell death is considered to occur after caspase activation within a few minutes ^[@ref-24]--\ [@ref-26]^.

However, we and other groups have demonstrated reversal of early stage apoptosis, such as externalization of phosphatidylserine (PS) in cultured primary cells and cancer cell lines ^[@ref-27]--\ [@ref-30]^. We have further demonstrated that dying cells can reverse apoptosis even after reaching the generally assumed "point of no return" ^[@ref-29]--\ [@ref-31]^, such as MOMP-mediated cytochrome *c* release, caspase-3 activation, DNA damage, nuclear fragmentation, and apoptotic body formation ^[@ref-4]--\ [@ref-9]^. Our observation of apoptosis reversal at late stages is further supported by an independent study, which shows recovery of cells after MOMP ^[@ref-32]^. To detect reversal of apoptosis in live animals, we have further developed a new *in vivo* caspase biosensor, designated "CaspaseTracker" ^[@ref-33]^, to identify and track somatic, germ and stem cells that recover after transient cell death inductions, and also potentially during normal development and homeostasis in *Drosophila melanogaster* after caspase activation ^[@ref-33],\ [@ref-34]^, the hallmark of apoptosis ^[@ref-4],\ [@ref-35]^. We proposed the term "anastasis" ^[@ref-30]^, which means "rising to life" in Greek, to describe this recovery from the brink of cell death. Anastasis appears to be an intrinsic cell survival phenomenon, as removal of cell death stimuli is sufficient to allow dying cells to recover ^[@ref-29]--\ [@ref-31],\ [@ref-33]^.

The physiological, pathological and therapeutic importance of anastasis is not yet known. We proposed that anastasis could be an unexpected tactic that cancer cells use to escape cancer therapy ^[@ref-29]--\ [@ref-31]^. Many tumours undergo dramatic initial responses to cell death-inducing radiation or chemotherapy ^[@ref-36]--\ [@ref-39]^; however, these cells relapse, and metastasis often occurs in most types of cancer ^[@ref-36]--\ [@ref-39]^. Therefore, the ability of cells to recover from transient induction of cell death may allow tumour cells to escape treatment, and survive and proliferate, resulting in relapse ^[@ref-29]--\ [@ref-31]^. Furthermore, cells may acquire new oncogenic mutations and transformation phenotypes during anastasis ^[@ref-30],\ [@ref-31]^, such as DNA damage caused by apoptotic nucleases. Therefore, anastasis could be one of the mechanisms underlying the observation that repeated tissue injury increases the risk of cancer in a variety of tissues ^[@ref-40]^, such as liver damage due to alcoholism ^[@ref-41]^, chronic thermal injury in the oesophagus induced by the consumption of very hot beverages ^[@ref-42]--\ [@ref-44]^, evolution of drug resistance in recurrent cancers ^[@ref-36]--\ [@ref-39],\ [@ref-45]^, and development of a second cancer during subsequent therapy ^[@ref-46]--\ [@ref-49]^. Anastasis can also occur in primary cardiac cells and neuronal cell lines ^[@ref-30],\ [@ref-31]^, and potentially in cardiomyocytes *in vivo* following transient ischemia ^[@ref-50]^. These findings suggest anastasis as an unexpected cellular protective mechanism. Therefore, uncovering the mechanisms of anastasis may provide new insights into the regulation of cell death and survival, and harnessing this mechanism via suppression or promotion of anastasis would aid treatment of intractable diseases including cancer, heart failure and neurodegeneration.

Our previous study demonstrated reversibility of ethanol-induced apoptosis at late stages in mouse primary liver cells, and revealed that new transcription is important to reverse apoptosis ^[@ref-30],\ [@ref-31]^. During recovery, we found up-regulation of genes involved in pro-survival pathways and DNA damage responses during anastasis (Bag3, Mcl1, Dnajb1, Dnajb9, Hsp90aa1, Hspa1b, and Hspb1, Mdm2) ^[@ref-30]^. Interestingly, inhibiting some of those genes by corresponding specific chemical inhibitors significantly suppresses anastasis ^[@ref-30]^. However, the molecular mechanism of anastasis remains to be elucidated. To study the cellular processes of anastasis, we performed time-course RNA microarray analysis to determine the gene expression profiles of the cultured mouse primary liver cells undergoing anastasis following transient exposure to ethanol that triggers apoptosis, and identified unique gene expression patterns during reversal of apoptosis. We also performed reverse transcription polymerase chain reaction (RT-PCR) to validate the gene expression patterns in the human liver cancer cell line, HepG2, during anastasis. Here, we present our time-course microarray data, which reveals the molecular signature of anastasis.

Methods
=======

Microarray
----------

Mouse primary liver cells were isolated from BALB/c mice using collagenase B and cultured as described ^[@ref-30],\ [@ref-51]^. The cells were cultured in in DMEM/F-12 (DMEM:nutrient mixture F-12) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin (Life Technologies, Carlsbad, CA, USA) at 37°C under an atmosphere of 5% CO ~2~/95% air. To induce apoptosis, cells were exposed to 4.5% ethanol for 5 hours (R0) in the culture medium (vol/vol). To allow recovery, dying cells were washed and further incubated in the fresh culture medium for 3 hours (R3), 6 hours (R6), 24 hours (R24), and 48 hours (R48). The untreated cells served as control (Ctrl). Three biological replicates were performed at each time point. Total RNA in the corresponding cell conditions was harvested using TRIzol Reagent (Life Technologies). The RNA was purified using the RNeasy Mini Kit (Qiagen, Cologne, Germany). Reverse transcription was performed using SABiosciences C-03 RT ^2^ First Strand Kit to construct cDNA (SABiosciences-Qiagen, Frederick, MD, USA). The cDNA samples were analysed using the Illumina MouseWG-6 v2.0 Expression BeadChip (Illumina, San Diego, CA, USA).

Gene expression data analysis
-----------------------------

The Partek Genomics Suite 6.6 (Partek, St. Louis, MO, USA) was used for principal component analysis (PCA) ^[@ref-52],\ [@ref-53]^. The Spotfire DecisionSite 9.1.2 (TIBCO, Palo Alto, CA, USA) platform was used to evaluate the fold change of gene expression levels between time points when compared with a common starting point, which is the control (Ctrl) ^[@ref-54]^. Signal values were converted into log ~2~ space and quality control tests were performed to ensure data integrity by comparing the signals of the three biological replicates at each time point. The fold change was based on averaged values of the three replicates at each time point; two-sample Student\'s *t*-test was used to determine statistical significance as *p*-values of less than 0.05, using the Partek Genomics Suite v6.5 (Partek Inc., St. Louis, MO, USA).

For the time-course gene expression analysis using Spotfire, all time points were compared with the time point Ctrl, which represents untreated cells. Spotfire was used to show the genes that displayed specific changes in gene expression after removal of cell death inducer for 3 hours (R3) and 6 hours (R6). Genes with specific and significant change (Log ~2~\> 1 or \<-1) in expression at the corresponding timepoint are highlighted. Interaction network analysis of the up-regulated genes during anastasis was performed using the GeneMANIA database ( <http://genemania.org/>) ^[@ref-55],\ [@ref-56]^.

Confocal microscopy
-------------------

Cells were incubated with 50 nM Mitotracker Red CMXRos and 250 ng/ml Hoechst 33342 (Invitrogen) for 20 minutes in culture medium to stain mitochondria and nuclei, respectively. The stained cells were washed and incubated with culture medium for 10 minutes, and then were fixed with 3.7% (wt/vol) paraformaldehyde in phosphate-buffer saline (PBS) solution for 20 minutes at room temperature in dark. The fixed cells were mounted on glass slide using ProLong Diamond Antifade Mountant (Invitrogen). Cell images were captured with the Zeiss LSM 780 confocal inverted microscope using a 40×, numerical aperture (NA) 1.4 plan-Apochromat objective (Carl Zeiss, Jena, Germany), and were analyzed using Zen 2013 or AxioVision 4.2 software (Carl Zeiss).

Reverse transcription polymerase chain reaction (RT-PCR)
--------------------------------------------------------

Human liver cancer cell line HepG2 (ATCC HB-8065) was cultured in DMEM/F-12, 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin (Life Technologies) at 37°C under an atmosphere of 5% CO ~2~/95% air. Apoptosis was induced by incubation of the cells with 4.5% ethanol in cell culture medium for 5 hours (R0). Then, the apoptotic dying cells were washed and then incubated in the fresh culture medium for 1 hour (R1), 2 hours (R2), 3 hours (R3), 4 hours (R4), 6 hours (R6), 9 hours (R9), 12 hours (R12), and 24 hours (R24). The untreated cells served as control (Ctrl). Total RNA in the corresponding cell conditions was harvested using QIAzol lysis reagent (Qiagen). The total RNA was purified using the RNeasy Mini Kit (Qiagen). Reverse transcription was performed using the SuperScript IV reverse transcriptase system (Thermo Fisher Scientific, Waltham, MA, USA). Primer sets for detecting targeted genes were designed using the Universal ProbeLibrary (Roche Applied Science, Madison, WI). Primer set for MMP10 was previously designed ^[@ref-57]^. Polymerase Chain Reaction (PCR) was performed using Taq DNA Polymerase and PCR protocol (New England BioLabs, Ipswich, MA, USA), with initial denaturation at 95°C for 2 minutes, followed by 30 cycles of denaturation at 95°C for 30 seconds, annealing at 60°C for 30 seconds, and extension at 72°C for 3 seconds. Electrophoresis of PCR products was performed using 4% agarose gel.

Results and discussion
======================

We have demonstrated that mouse primary liver cells can reverse the apoptotic process at the execution stage ^[@ref-30],\ [@ref-31]^, despite reaching important checkpoints commonly believed to be the "point of no return" ^[@ref-4]--\ [@ref-9]^, including caspase-3 activation, DNA damage, and cell shrinkage. To pursue the mechanisms of anastasis, we performed time-course high-throughput microarray to evaluate gene expression profiles during reversal of ethanol-induced apoptosis in mouse primary liver cells. RNA samples were collected from the untreated primary liver cells (Ctrl), the cells treated with 4.5% ethanol for 5 hours when cells exhibited hallmarks of apoptosis (R0), and the treated cells that were then washed and cultured in fresh medium for 3 (R3), 6 (R6), 24 (R24) and 48 (R48) hours. Apoptosis was confirmed in the ethanol-treated cells (R0), which displayed hallmarks of apoptosis, including plasma membrane blebbing, cell shrinkage, cleavage of caspase-3 and its substrates, such as PARP and ICAD ( [Figure 1A and B](#f1){ref-type="fig"}, images reprinted with permission ^[@ref-30]^). The features of apoptosis vanished after removal of the cell death inducer (R24), indicating recovery of the cells ( [Figure 1A and B](#f1){ref-type="fig"}). Three biological replicates were performed at each time point. The principal component analysis indicated that all three biological replicates of each time point exhibited a very high correlation, as indicated by clustering, for the dataset of all 18 samples ( [Figure 2A](#f2){ref-type="fig"}; [Supplementary Figure 1](#SM1){ref-type="other"}; see Data availability). The unsupervised hierarchical clustering confirms the similarity between all the replicates at each time point ( [Figure 2B](#f2){ref-type="fig"}; see Data availability; [Supplementary Figure 2](#SM1){ref-type="other"}).

![Flow chart for experimental design.\
Mouse primary liver cells were treated with 4.5% ethanol for 5 hours (R0) and then washed and cultured in fresh medium for 3 (R3), 6 (R6), 24 (R24), and 48 (R48) hours. The untreated cells served as control (Ctrl). ( **A**) Time-lapse live-cell light microscopy and ( **B)** Western blot analysis validated apoptosis to occur at R0, and anastasis at R24. Cells were collected at the indicated timepoints of ( **A**) for RNA extraction. Gene expression profiling was performed by microarray, and analysed by Spotfire. The images from [Figure 1A and B](#f1){ref-type="fig"} are adopted from the *Mol Biol Cell* 23, 2240--52 (2012) ^[@ref-30]^. Reprinted with permission.](f1000research-6-11669-g0000){#f1}

![Technical validation of microarray data.\
The three biological replicate samples of microarray data were shown to cluster together by using ( **A**) principal component analysis (PCA) and ( **B**) unsupervised hierarchical clustering of the RNA microarray data of eighteen samples.](f1000research-6-11669-g0001){#f2}

Genes that display significant changes in expression during anastasis at the earliest time point of 3 hours, following the removal of the cell death inducer, may represent critical first responders of anastasis ( [Figure 3A](#f3){ref-type="fig"}, [Table 1](#T1){ref-type="table"}), including transcription factors of the activator protein-1 (AP-1) family (Atf3, Fos, Fosb, Jun, Junb), transforming growth factor-β (TGF-β) signal pathway and its related regulators (Inhba, Snai1, Tgif1, Sox4, Sox9, Klf4, Klf6, Klf9), pro-survival Bcl-2 family member (Bag3), inhibitor of p53 (Mdm2), anti-oxidation (Hmox1), anti-proliferation (Btg1), DNA damage (Ddit3, Ddit4), vesicular trafficking (Vps37b) and stress-inducible (Dnajb1, Dnajb9, Herpud1, Hspb1, Hspa1b) responses. Starting at 6 hours of anastasis, other groups of gene pathways display the peak of transcription, such as cell cycle arrest (Cdkn1a, Trp53inp1), autophagy (Atg12, Sqstm1), and cell migration (Mmp9, Mmp10 and Mmp13) ( [Figure 3B](#f3){ref-type="fig"}, [Table 1](#T1){ref-type="table"} and [Table 2](#T2){ref-type="table"}). Expression of potent angiogenic factors, such as Vegfa and Angptl4, are up-regulated at 3 and 6 hours of anastasis, respectively ( [Table 1](#T1){ref-type="table"} and [Table 2](#T2){ref-type="table"}). Histones display up- (Hist1h2ae, H2afj) and down- (Hist1h2ak, Hist1h2ag, Hist1h2ap, Hist1h2af, Hist2h2ac, Hist1h2ah) regulations during the first 6 hours of anastasis ( [Table 2](#T2){ref-type="table"} and [Table 3](#T3){ref-type="table"}). Changes in expression of most of these genes peak at the 3--6-hour time points after removal of the apoptotic stimulus and then return to baseline ( [Figure 3A and B](#f3){ref-type="fig"}; [Supplementary Figure 2](#SM1){ref-type="other"}). Interestingly, certain genes such as splicing of pre-mRNA (Rnu6), and growth arrest and DNA repair (Gadd45g) stay up-regulated during both apoptosis and anastasis ( [Figure 3C](#f3){ref-type="fig"}, [Table 4](#T4){ref-type="table"}).

![Change of gene expression profiles during reversal of apoptosis in mouse primary liver cells.\
Log ~2~-fold change of gene expression comparison between untreated cells (Ctrl), ethanol-induced apoptotic cells (R0), and induced cells that were then washed and further cultured in fresh medium for 3 (R3), 6 (R6), 24 (R24), and 48 (R48) hours. Genes that displayed specific ( **A**) up-regulation at R3, ( **B**) up- or down-regulation at R6, and ( **C**) up-regulation anytime during the period from R0 to R6 with absolute log ~2~ fold change \>1 are highlighted. The log ~2~ signal values from three biological replicates were averaged (geometric mean) for each time point.](f1000research-6-11669-g0002){#f3}

###### List of top 67 up-regulated genes at 3 ^rd^ hour (R3) of anastasis, with log ~2~ fold change \>1, compared with Ctrl (untreated cells).

  --------------------------------------------------------------------------------------------------------------------
  Sort\   Gene Symbol     Definition                                                  Accession        Log ~2~ fold\
  Order                                                                                                change\
                                                                                                       R3 vs. Ctrl
  ------- --------------- ----------------------------------------------------------- ---------------- ---------------
  1       Atf3            activating transcription factor 3                           NM_007498.2      4.08867

  2       Hspa1b          heat shock protein 1B                                       NM_010478.2      3.88264

  3       Fosb            FBJ osteosarcoma oncogene B                                 NM_008036.2      3.40725

  4       Fos             FBJ osteosarcoma oncogene                                   NM_010234.2      3.03649

  5       Egr2            no definition                                               NM_010118.1      2.82862

  6       Dnajb1          DnaJ (Hsp40) homolog, subfamily B, member 1                 NM_018808.1      2.78017

  7       Dusp1           dual specificity phosphatase 1                              NM_013642.2      2.533

  8       Sox9            SRY-box containing gene 9                                   NM_011448.2      2.37421

  9       Zfp36           zinc finger protein 36                                      NM_011756.4      2.33651

  10      Mfsd11          no definition                                               AK007898         2.31434

  11      Hspb1           no definition                                               NM_013560        2.30989

  12      Jun             Jun oncogene                                                NM_010591.1      2.28214

  13      Ddit4           DNA-damage-inducible transcript 4                           NM_029083.1      2.25327

  14      Vegfa           vascular endothelial growth factor A (Vegfa), transcript\   NM_001025250.2   2.19637
                          variant 1                                                                    

  15      Herpud1         homocysteine-inducible, ER stress-inducible,\               NM_022331.1      2.17913
                          ubiquitin-like domain member 1                                               

  16      Ddit3           DNA-damage inducible transcript 3                           NM_007837.2      2.16334

  17      Mdm2            transformed mouse 3T3 cell double minute 2                  NM_010786.3      2.11273

  18      Chac1           ChaC, cation transport regulator-like 1                     NM_026929.3      2.08317

  19      Arc             activity regulated cytoskeletal-associated protein          NM_018790.2      1.99046

  20      Dnajb9          DnaJ (Hsp40) homolog, subfamily B, member 9                 NM_013760.4      1.961

  21      Zfand2a         zinc finger, AN1-type domain 2A                             NM_133349.2      1.8778

  22      Hes1            hairy and enhancer of split 1                               NM_008235.2      1.85536

  23      Bag3            BCL2-associated athanogene 3                                NM_013863.4      1.85303

  24      LOC100048331    PREDICTED: similar to DnaJ (Hsp40) homolog,\                XR_034509.1      1.82115
                          subfamily A, member 4                                                        

  25      Hmox1           heme oxygenase                                              NM_010442.1      1.82111

  26      Hspa5           heat shock protein 5                                        NM_022310.2      1.8205

  27      Dlx2            distal-less homeobox 2                                      NM_010054.1      1.62035

  28      6430590I03Rik   no definition                                               XM_489535        1.61804

  29      Junb            Jun-B oncogene (Junb)                                       NM_008416.1      1.61245

  30      LOC381140       no definition                                               XM_355056.1      1.57312

  31      5430411C19Rik   PREDICTED: RIKEN cDNA 5430411C19 gene                       XM_001478639.1   1.56805

  32      Hspa1a          no definition                                               NM_010479        1.56028

  33      Csrnp1          AXIN1 up-regulated 1                                        NM_153287.3      1.46632

  34      Tnfaip3         tumor necrosis factor, alpha-induced protein 3              NM_009397.2      1.45772

  35      LOC100048105    PREDICTED: similar to Ubc protein, transcript variant 1     XM_001479832.1   1.45617

  36      Bhlhe40         basic helix-loop-helix domain containing, class B2          NM_011498.4      1.39137

  37      Dyrk3           dual-specificity tyrosine-(Y)-phosphorylation regulated\    NM_145508.2      1.3612
                          kinase 3                                                                     

  38      Egr1            early growth response 1                                     NM_007913.5      1.35873

  39      Klf9            PREDICTED: RIKEN cDNA 2310051E17 gene                       XM_001479552.1   1.35306

  40      Snai1           snail homolog 1                                             NM_011427.2      1.35105

  41      Dusp2           dual specificity phosphatase 2                              NM_010090.2      1.34955

  42      Ubg             no definition                                               no accession     1.3258

  43      BC022687        cDNA sequence BC022687                                      NM_145450.3      1.31366

  44      Btg1            B-cell translocation gene 1, anti-proliferative             NM_007569.1      1.2996

  45      LOC100046232    PREDICTED: similar to NFIL3/E4BP4 transcription\            XM_001475817.1   1.27509
                          factor                                                                       

  46      Hsph1           no definition                                               NM_013559.1      1.2662

  47      Hist1h2ae       histone cluster 1, H2ae                                     NM_178187.3      1.26359

  48      mtDNA_ND4L      no definition                                               no accession     1.2474

  49      Dnajb4          DnaJ (Hsp40) homolog, subfamily B, member 4                 NM_025926.1      1.24227

  50      Klf4            Kruppel-like factor 4                                       NM_010637.1      1.23324

  51      Tgif1           TGFB-induced factor homeobox 1                              NM_009372.2      1.22645

  52      Klf6            Kruppel-like factor 6                                       NM_011803.2      1.22027

  53      Ppp1r10         protein phosphatase 1, regulatory subunit 10                NM_175934.2      1.21047

  54      Gm16516         no definition                                               NM_025293.1      1.20916

  55      Ifrd1           interferon-related developmental regulator 1                NM_013562.1      1.19232

  56      Slc23a3         solute carrier family 23 (nucleobase transporters),\        NM_194333.3      1.18765
                          member 3                                                                     

  57      Mfsd11          major facilitator superfamily domain containing 11          NM_178620.3      1.16606

  58      Gm4589          PREDICTED: hypothetical protein LOC100045678                XM_001475512.1   1.16498

  59      Klf9            Kruppel-like factor 9                                       NM_010638.4      1.12553

  60      Siah2           seven in absentia 2                                         NM_009174.3      1.11181

  61      Map1lc3b        microtubule-associated protein 1 light chain 3 beta         NM_026160.3      1.10454

  62      Plk2            polo-like kinase 2                                          NM_152804.1      1.05963

  63      Fgf21           fibroblast growth factor 21                                 NM_020013.4      1.05538

  64      Id4             inhibitor of DNA binding 4                                  NM_031166.2      1.04488

  65      Csf1            colony stimulating factor 1                                 NM_007778.3      1.03533

  66      Bbc3            BCL2 binding component 3 (Bbc3)                             NM_133234.1      1.03288

  67      6230400G14Rik   no definition                                               no accession     1.02327
  --------------------------------------------------------------------------------------------------------------------

###### List of top 109 up-regulated genes at 6 ^th^ hour (R6) of anastasis, with log ~2~ fold change \>0.93, compared with Ctrl (untreated cells).

  -----------------------------------------------------------------------------------------------------------------------
  Sort\   Gene Symbol     Definition                                                     Accession        Log ~2~ fold\
  Order                                                                                                   change\
                                                                                                          R6 vs. Ctrl
  ------- --------------- -------------------------------------------------------------- ---------------- ---------------
  1       Inhba           inhibin beta-A                                                 NM_008380.1      3.86584

  2       Mmp10           matrix metallopeptidase 10                                     NM_019471.2      3.39644

  3       Lce1f           late cornified envelope 1F                                     NM_026394.2      2.99957

  4       Serpinb2        serine (or cysteine) peptidase inhibitor, clade B,\            NM_011111.3      2.77022
                          member 2                                                                        

  5       Serpina3h       serine (or cysteine) peptidase inhibitor, clade A,\            NM_001034870.2   2.65107
                          member 3H                                                                       

  6       Mmp13           matrix metallopeptidase 13                                     NM_008607.1      2.62637

  7       Ptpn22          protein tyrosine phosphatase, non-receptor type 22             NM_008979.1      2.45292

  8       Rgs16           regulator of G-protein signaling 16                            NM_011267.2      2.18647

  9       Nppb            natriuretic peptide precursor type B                           NM_008726.3      2.15071

  10      Has1            hyaluronan synthase1                                           NM_008215.1      2.14235

  11      Dusp5           no definition                                                  XM_140740.3      2.09536

  12      Sqstm1          sequestosome 1                                                 NM_011018.2      2.07477

  13      Nupr1           nuclear protein 1                                              NM_019738.1      2.06313

  14      Sphk1           sphingosine kinase 1 (Sphk1), transcript variant 2             NM_025367.5      1.94856

  15      Dusp4           dual specificity phosphatase 4                                 NM_176933.4      1.85742

  16      Klhl21          kelch-like 21                                                  NM_001033352.3   1.84531

  17      Lor             loricrin                                                       NM_008508.2      1.81763

  18      Ndrg1           N-myc downstream regulated gene 1                              NM_008681.2      1.79158

  19      Srxn1           sulfiredoxin 1 homolog                                         NM_029688.4      1.78335

  20      Hk2             PREDICTED: hypothetical protein LOC100047934                   XM_001478074.1   1.7519

  21      Txnrd1          thioredoxin reductase 1 (Txnrd1), transcript variant 1         NM_001042523.1   1.75148

  22      Angptl4         no definition                                                  NM_020581        1.72982

  23      Trib3           tribbles homolog 3                                             NM_175093.2      1.72246

  24      C330006P03Rik   no definition                                                  no accession     1.71297

  25      Cdkn1a          cyclin-dependent kinase inhibitor 1A                           NM_007669.2      1.69118

  26      Gdf15           growth differentiation factor 15                               NM_011819.1      1.67887

  27      Prkg2           protein kinase, cGMP-dependent, type II                        NM_008926.3      1.67374

  28      H2afj           H2A histone family, member J                                   NM_177688.2      1.64825

  29      Hbegf           heparin-binding EGF-like growth factor                         NM_010415.1      1.61893

  30      Trp53inp1       transformation related protein 53 inducible nuclear\           NM_021897.1      1.61348
                          protein 1                                                                       

  31      Gfpt2           glutamine fructose-6-phosphate transaminase 2                  NM_013529.2      1.58159

  32      Slc7a11         no definition                                                  AK037490         1.57761

  33      Ndrg1           no definition                                                  NM_008681        1.5652

  34      Gprc5a          G protein-coupled receptor, family C, group 5, member A        NM_181444.3      1.51339

  35      Ibrdc3          no definition                                                  XM_204030        1.49816

  36      Ngf             nerve growth factor, beta                                      NM_013609.1      1.48619

  37      Lce1d           late cornified envelope 1D                                     NM_027137.2      1.44977

  38      Tpsab1          tryptase alpha/beta 1                                          NM_031187.2      1.44267

  39      Htr2b           5-hydroxytryptamine (serotonin) receptor 2B                    NM_008311.2      1.43265

  40      Sox4            SRY-box containing gene 4                                      NM_009238.2      1.41763

  41      Il1rl1          interleukin 1 receptor-like 1 (Il1rl1), transcript variant 1   NM_001025602.1   1.3994

  42      Prr9            RIKEN cDNA A030004J04 gene (A030004J04Rik)                     NM_175424.3      1.36416

  43      Vgf             VGF nerve growth factor inducible                              NM_001039385.1   1.35246

  44      Errfi1          ERBB receptor feedback inhibitor 1                             NM_133753.1      1.34582

  45      Il6             interleukin 6                                                  NM_031168.1      1.33283

  46      Gprc5a          no definition                                                  NM_181444        1.31955

  47      Antxr2          anthrax toxin receptor 2                                       NM_133738.1      1.30719

  48      Tgif1           TGFB-induced factor homeobox 1                                 NM_009372.2      1.29814

  49      Krt8            keratin 8                                                      NM_031170.2      1.28819

  50      2300009A05Rik   PREDICTED: RIKEN cDNA 2300009A05 gene,\                        XM_898537.2      1.26684
                          transcript variant 3                                                            

  51      Dppa5a          developmental pluripotency associated 5                        NM_025274.1      1.258

  52      Mt2             metallothionein 2                                              NM_008630.2      1.2441

  53      Plaur           plasminogen activator, urokinase receptor                      NM_011113.3      1.22553

  54      Thbd            thrombomodulin                                                 NM_009378.2      1.22252

  55      LOC100047353    PREDICTED: similar to myocardial vascular inhibition\          XM_001477963.1   1.22053
                          factor                                                                          

  56      Csf2            colony stimulating factor 2 (granulocyte-macrophage)           NM_009969.4      1.22019

  57      Map2k1          mitogen-activated protein kinase kinase 1                      NM_008927.3      1.21788

  58      Dpp7            dipeptidylpeptidase 7                                          NM_031843.2      1.21624

  59      LOC672274       PREDICTED: similar to Transcription factor SOX-4               XR_003788.1      1.21149

  60      Blcap           bladder cancer associated protein homolog                      NM_016916.3      1.21046

  61      Zfc3h1          no definition                                                  NM_001033261.2   1.20585

  62      Dusp6           dual specificity phosphatase 6                                 NM_026268.1      1.20441

  63      Areg            amphiregulin                                                   NM_009704.3      1.19656

  64      C630022N07Rik   no definition                                                  no accession     1.19569

  65      Denr            density-regulated protein                                      NM_026603.1      1.18464

  66      Slc3a2          solute carrier family 3 (activators of dibasic and neutral\    NM_008577.3      1.18244
                          amino acid transport), member 2                                                 

  67      Ern1            endoplasmic reticulum (ER) to nucleus signalling 1             NM_023913.2      1.15145

  68      Dnmt3l          DNA (cytosine-5-)-methyltransferase 3-like (Dnmt3l),\          NM_001081695.1   1.13992
                          transcript variant 2                                                            

  69      D130007C19Rik   no definition                                                  AK051152         1.13724

  70      LOC100046401    PREDICTED: similar to SDR2                                     XR_032583.1      1.1332

  71      Sh3bp2          SH3-domain binding protein 2                                   NM_011893.2      1.11999

  72      Tgoln1          trans-golgi network protein                                    NM_009443.3      1.11454

  73      Gm12226         similar to oxidative stress responsive 1 (Rp23-297j14.5)       NM_001099322.1   1.11231

  74      Stk40           no definition                                                  NM_028800        1.11149

  75      Marcksl1        MARCKS-like 1 (Marcksl1), mRNA.                                NM_010807.3      1.09791

  76      Ypel5           yippee-like 5 (Drosophila) (Ypel5), mRNA.                      NM_027166.3      1.08882

  77      Fam180a         No definition                                                  NM_173375        1.08779

  78      Creb3l2         cAMP responsive element binding protein 3-like 2\              NM_178661.3      1.08689
                          (Creb3l2), mRNA.                                                                

  79      Ly96            lymphocyte antigen 96 (Ly96), mRNA.                            NM_016923.1      1.06285

  80      Igf2bp2         insulin-like growth factor 2 mRNA binding protein 2\           NM_183029.1      1.06145
                          (Igf2bp2), mRNA.                                                                

  81      Mafg            v-maf musculoaponeurotic fibrosarcoma oncogene\                NM_010756.3      1.05594
                          family, protein G                                                               

  82      Cttnbp2nl       No definition                                                  NM_030249        1.04697

  83      Col20a1         PREDICTED: collagen, type XX, alpha 1 (Col20a1),\              XM_181390.5      1.04143
                          mRNA.                                                                           

  84      Vps37b          vacuolar protein sorting 37B (yeast) (Vps37b), mRNA.           NM_177876.4      1.03812

  85      A530046M15      No definition                                                  XM_488663        1.03773

  86      Eid3            EP300 interacting inhibitor of differentiation 3 (Eid3),\      NM_025499.2      1.03567
                          mRNA.                                                                           

  87      Nabp1           oligonucleotide/oligosaccharide-binding fold containing\       NM_028696.2      1.0351
                          2A (Obfc2a), mRNA.                                                              

  88      Pqlc1           PQ loop repeat containing 1 (Pqlc1), mRNA.                     NM_025861.2      1.03363

  89      Whrn            whirlin (Whrn), transcript variant 6, mRNA.                    NM_001008795.1   1.0255

  90      Cish            cytokine inducible SH2-containing protein (Cish),\             NM_009895.3      1.02328
                          mRNA.                                                                           

  91      Ptpre           protein tyrosine phosphatase, receptor type, E (Ptpre),\       NM_011212.2      1.01915
                          mRNA.                                                                           

  92      Bach1           BTB and CNC homology 1 (Bach1), mRNA.                          NM_007520.2      1.01808

  93      Cyb5r1          cytochrome b5 reductase 1 (Cyb5r1), mRNA.                      NM_028057.2      1.01401

  94      Slc1a4          solute carrier family 1 (glutamate/neutral amino acid\         NM_018861.2      1.00471
                          transporter), member 4                                                          

  95      Mmd             no definition                                                  AK033889         0.998067

  96      Slc6a9          solute carrier family 6 (neurotransmitter transporter,\        NM_008135.4      0.994683
                          glycine), member 9                                                              

  97      LOC100047963    PREDICTED: similar to ADIR1                                    XM_001479238.1   0.994667

  98      Atf4            activating transcription factor 4                              NM_009716.2      0.982833

  99      Cttnbp2nl       CTTNBP2 N-terminal like                                        NM_030249.3      0.970113

  100     Mmp9            matrix metallopeptidase 9                                      NM_013599.2      0.968853

  101     Hmga1           high mobility group AT-hook 1                                  NM_016660.2      0.96846

  102     Phlda1          pleckstrin homology-like domain, family A, member 1            NM_009344.1      0.963867

  103     Aars            alanyl-tRNA synthetase                                         NM_146217.3      0.962397

  104     Angpt2          angiopoietin 2                                                 NM_007426.3      0.95926

  105     Zswim4          zinc finger, SWIM domain containing 4                          NM_172503.3      0.957373

  106     Selk            no definition                                                  NM_019979.1      0.954917

  107     Abhd2           abhydrolase domain containing 2                                NM_018811.6      0.954587

  108     Krtap4-16       predicted gene, OTTMUSG00000002196                             NM_001013823.1   0.95438

  109     Atg12           autophagy-related 12                                           NM_026217.1      0.94998
  -----------------------------------------------------------------------------------------------------------------------

###### List of top 50 down-regulated genes at 6 ^th^ hour (R6) of anastasis, with log ~2~ fold change \<-0.95, compared with Ctrl (untreated cells).

  ---------------------------------------------------------------------------------------------------------------------
  Sort\   Gene Symbol     Definition                                                      Accession     Log ~2~ fold\
  Order                                                                                                 change\
                                                                                                        R6 vs. Ctrl
  ------- --------------- --------------------------------------------------------------- ------------- ---------------
  1       Hist1h2ak       histone cluster 1, H2ak                                         NM_178183.1   -1.91761

  2       Hist1h2ag       histone cluster 1, H2ag                                         NM_178186.2   -1.76767

  3       Hist1h2ap       histone cluster 1, H2ao                                         NM_178185.1   -1.7396

  4       Hist1h2af       histone cluster 1, H2af                                         NM_175661.1   -1.6854

  5       Hist2h2ac       histone cluster 2, H2ac                                         NM_175662.1   -1.6272

  6       Slc1a3          solute carrier family 1 (glial high affinity glutamate\         NM_148938.2   -1.61827
                          transporter), member 3                                                        

  7       9930013L23Rik   no definition                                                   AK018112      -1.59264

  8       Hist1h2ah       histone cluster 1, H2ah                                         NM_175659.1   -1.57002

  9       Hist1h2al       PREDICTED: predicted gene, EG667728                             XR_035278.1   -1.56907

  10      Hist1h2ad       histone cluster 1, H2ad                                         NM_178188.3   -1.56233

  11      Scel            sciellin                                                        NM_022886.2   -1.48845

  12      Hist1h2ai       histone cluster 1, H2ai                                         NM_178182.1   -1.40187

  13      Fzd2            frizzled homolog 2                                              NM_020510.2   -1.38203

  14      Sdpr            serum deprivation response                                      NM_138741.1   -1.38033

  15      Hs3st1          heparan sulfate (glucosamine) 3-O-sulfotransferase 1            NM_010474.1   -1.32418

  16      Hist2h2ab       histone cluster 2, H2ab                                         NM_178213.3   -1.30977

  17      Kif2c           kinesin family member 2C (Kif2c) XM_986361                      NM_134471.3   -1.21821

  18      Fam198b         RIKEN cDNA 1110032E23 gene (1110032E23Rik)                      NM_133187.2   -1.1988

  19      Cdc42ep2        CDC42 effector protein (Rho GTPase binding) 2                   NM_026772.1   -1.19681

  20      Lurap1l         DNA segment, Chr 4, Brigham & Women\'s Genetics 0951\           NM_026821.4   -1.18656
                          expressed (D4Bwg0951e)                                                        

  21      Medag           RIKEN cDNA 6330406I15 gene                                      NM_027519.1   -1.18243

  22      Disp1           dispatched homolog 1                                            NM_026866.2   -1.18107

  23      Bmp4            bone morphogenetic protein 4                                    NM_007554.2   -1.16637

  24      Rab27a          RAB27A, member RAS oncogene family                              NM_023635.4   -1.13917

  25      Aurka           aurora kinase A                                                 NM_011497.3   -1.12507

  26      Ncaph           non-SMC condensin I complex, subunit H                          NM_144818.1   -1.12132

  27      Fignl1          fidgetin-like 1                                                 NM_021891.2   -1.10521

  28      Dbp             D site albumin promoter binding protein                         NM_016974.1   -1.09945

  29      Meis2           Meis homeobox 2 (Meis2), transcript variant 2                   NM_010825.2   -1.08487

  30      Synpo           PREDICTED: synaptopodin, transcript variant 2                   XM_981156.1   -1.08076

  31      Hist1h2an       histone cluster 1, H2an                                         NM_178184.1   -1.0804

  32      Fam111a         RIKEN cDNA 4632417K18 gene (4632417K18Rik)                      NM_026640.2   -1.07617

  33      Aurkb           aurora kinase B                                                 NM_011496.1   -1.07507

  34      Anln            anillin, actin binding protein                                  NM_028390.2   -1.07218

  35      Tuft1           tuftelin 1                                                      NM_011656.2   -1.06969

  36      Cxcl12          chemokine (C-X-C motif) ligand 12 (Cxcl12), transcript\         NM_021704.2   -1.0664
                          variant 1                                                                     

  37      Sipa1l1         signal-induced proliferation-associated 1 like 1                NM_172579.1   -1.03567

  38      Rbms2           RNA binding motif, single stranded interacting protein 2        NM_019711.2   -1.03096

  39      Wdr6            WD repeat domain 6                                              NM_031392.2   -1.02705

  40      Tk1             thymidine kinase 1                                              NM_009387.1   -1.02669

  41      Mylk            myosin, light polypeptide kinase                                NM_139300.3   -1.01621

  42      Slc9a3r1        solute carrier family 9 (sodium/hydrogen exchanger),\           NM_012030.2   -1.0137
                          member 3 regulator 1                                                          

  43      Kif22           kinesin family member 22                                        NM_145588.1   -1.01346

  44      Speer3          spermatogenesis associated glutamate (E)-rich protein 3         NM_027650.2   -1.01229

  45      Mrgprf          MAS-related GPR, member F                                       NM_145379.2   -1.01038

  46      Bub1b           budding uninhibited by benzimidazoles 1 homolog, beta           NM_009773.1   -1.00547

  47      Pcgf5           polycomb group ring finger 5                                    NM_029508.3   -1.00513

  48      Marcks          myristoylated alanine rich protein kinase C substrate           NM_008538.2   -0.973133

  49      Fam83d          2310007D09Rik                                                   NM_027975.1   -0.966323

  50      Slc16a4         solute carrier family 16 (monocarboxylic acid transporters),\   NM_146136.1   -0.96461
                          member 4                                                                      
  ---------------------------------------------------------------------------------------------------------------------

###### List of top 15 up-regulated genes during apoptosis (R0) and anastasis (R3 and R6), with log ~2~ fold change \>1 either on R0, R3, or R6, compared with Ctrl (untreated cells).

  -------------------------------------------------------------------------------------------------------------------
                                                              Log ~2~ fold change                         
  ---- --------------- --------------------- ---------------- --------------------- ---------- ---------- -----------
  1    Rnu6            U6 small nuclear\     NR_003027.1      2.75163               2.08117    1.63203    0.315967
                       RNA                                                                                

  2    Med23           no definition         AK042346         2.53792               2.37555    1.87041    0.70258

  3    Prf1            perforin 1            NM_011073.2      2.40981               2.36444    1.1381     0.262567

  4    F830002E14Rik   no definition         AK089567         2.18787               0.549207   0.731387   ‐0.08211

  5    Slc11a1         solute carrier\       NM_013612.1      1.51837               2.24547    1.50337    0.53101
                       family 11\                                                                         
                       (proton-coupled\                                                                   
                       divalent metal\                                                                    
                       ion transporters),\                                                                
                       member 1                                                                           

  6    Hist1h4a        histone cluster\      NM_178192.1      1.46352               1.19978    0.87087    0.08441
                       1, H4a                                                                             

  7    Hist1h4j        histone cluster\      NM_178210.1      1.4276                1.15198    0.801933   0.241233
                       1, H4j                                                                             

  8    2310005L22Rik   no definition         no accession     1.19244               1.23574    0.79319    0.0878833

  9    2810026P18Rik   no definition         no accession     1.12393               1.14743    0.527953   ‐0.31585

  10   Gadd45g         growth arrest and\    NM_011817.1      1.04177               1.85013    1.0444     ‐0.324567
                       DNA-damage-\                                                                       
                       inducible 45\                                                                      
                       gamma                                                                              

  11   Sppl3           no definition         AK047886         1.01269               1.85284    1.22205    0.51878

  12   1810026B05Rik   no definition         XM_489186        0.9892                0.92441    0.742947   ‐0.257843

  13   BC030476        cDNA sequence\        NM_173421.1      0.98391               1.51116    0.495447   0.2612
                       BC030476                                                                           

  14   Zbtb2           zinc finger and\      NM_001033466.1   0.882457              1.25171    0.253943   ‐0.116403
                       BTB domain\                                                                        
                       containing 2                                                                       

  15   Ppp1r15a        myeloid\              NM_008654.1      0.862993              2.48696    1.82011    ‐0.25323
                       differentiation\                                                                   
                       primary response\                                                                  
                       gene 116                                                                           
  -------------------------------------------------------------------------------------------------------------------

We further observed the similar changes in gene expressions during anastasis in cultured human liver cancer HepG2 cells ( [Figure 4](#f4){ref-type="fig"}; see Data availability). The untreated HepG2 cells displayed tubular and filamentous mitochondria in the cells that spread on the substrate ( [Figure 4A *i*, 4B](#f4){ref-type="fig"}). After exposure to 4.5% ethanol for 5 hours, the treated cells displayed morphological hallmarks of apoptosis, such as mitochondrial fragmentation, nuclear condensation, plasma membrane blebbing, and cell shrinkage ( [Figure 4A *ii*, 4B](#f4){ref-type="fig"}). After washed and incubated with fresh culture medium, the treated cells regained normal morphology ( [Figure 4A *iii*, 4B](#f4){ref-type="fig"}). Interestingly, the HepG2 cells that underwent anastasis displayed the increase in micronuclei formation ( [Figure 4B](#f4){ref-type="fig"}), which is the biomarker of DNA damage ^[@ref-58]^, as we previously observed in mouse primary liver cells, mouse embryonic fibroblast NIH 3T3 cells, human cervical cancer HeLa cells, and human small cell lung carcinoma H446 cells ^[@ref-30],\ [@ref-31]^. By using reverse transcription polymerase chain reaction (RT-PCR), we verified our microarray data on HepG2 cells during reversal of ethanol-induced apoptosis, and found similar gene expression patterns during anastasis, including changes in mRNA levels of ANGPTL4, ATF3, ATG12, CDKN1A, FOS, HSPA1B, JUN, MDM2, MMP10 and SOX9 ( [Figure 4C](#f4){ref-type="fig"}; [Supplementary Figure 3](#SM1){ref-type="other"}). This suggests that the mechanism of anastasis is conserved between primary and cancer cells.

![Change of gene expressions during reversal of apoptosis in human liver cancer HepG2 cells.\
( **A**) Confocal and differential interference contrast (DIC) microscopy of untreated liver cells ( ***i*** Untreated), cells that were exposed to 4.5% ethanol for 5 hours ( ***ii*** Treated), and the treated cells that were washed to remove apoptosis inducer and further cultured for 6 hours ( ***iii*** Washed). Merged images, mitochondria (red) and nuclei (blue) were visualized by confocal microscopy and cell morphology by DIC. Monochrome images, nucleus of the corresponding cells. Scale bar, 10 μm. ( **B**) Quantification of the apoptotic response and its reversal on HepG2 cells. Percentage of the untreated cells, the treated cells (4.5% ethanol, 5 hours) and the washed cells (24 hours) showing mitochondrial fragmentation, nuclear condensation, cell shrinkage, and formation of micronuclei. ( **C**) RT-PCR gel analysis of changes in mRNA levels of ANGPTL4, ATF3, ATG12, CDKN1A, FOS, GUSB, HSPA1B, JUN, MDM2, MMP10 and SOX9 on the untreated (Ctrl), the treated (R0, 4.5% ethanol for 5 hours), and the treated cells that were then washed and incubated in fresh medium for 1 hour (R1), 2 hours (R2), 3 hours (R3), 4 hours (R4), 6 hours (R6), 9 hours (R9), 12 hours (R12), and 24 hours (R24). GUSB serves as housekeeping gene. Sequences of primer sets for detecting targeted genes are available in [Table 5](#T5){ref-type="table"}.](f1000research-6-11669-g0003){#f4}

###### List of primer sequences for RT-PCR.

  Gene      Accession number   Forward primer              Reverse primer              Amplicon
  --------- ------------------ --------------------------- --------------------------- ----------
  ANGPTL4   NM_139314.2        gacaagaactgcgccaaga         gccgttgaggttggaatg          72
  ATF3      NM_001674.3        cgtgagtcctcggtgctc          gcctgggtgttgaagcat          112
  ATG12     NM_004707.3        tcttccgctgcagtttcc          gtctcccacagcctttagca        87
  CDKN1A    NM_000389.4        tgggtggtaccctctgga          tgaatttcataaccgcctgtg       65
  FOS       NM_005252          ctggcgttgtgaagaccat         ccttttctcttcttcttctggagat   95
  GUSB      NM_000181.3        cgccctgcctatctgtattc        tccccacagggagtgtgtag        91
  HSPA1B    NM_005346.4        gggtcaggccctaccatt          caacagtccacctcaaagacaa      77
  JUN       NM_002228.3        ccaaaggatagtgcgatgttt       ctgtccctctccactgcaac        62
  MDM2      NM_002392.5        tctgatagtatttccctttcctttg   tgttcacttacaccagcatcaa      137
  MMP10     NM_002425.2        gcattttggccctctcttc         cagggtatggatgcctcttg        147
  SOX9      NM_000346.3        gtacccgcacttgcacaac         tctcgctctcgttcagaagtc       74

The change in transcriptional profiles during anastasis provides us mechanistic insights into how dying cells could reverse apoptosis ( [Figure 5](#f5){ref-type="fig"}). In early anastasis, our data reveals that the regulators of the TGF-β signalling pathway, which control various fundamental cellular and pathological process, including proliferation, cell survival, apoptosis, cell migration, and transformation ^[@ref-59]--\ [@ref-62]^, are upregulated. The activation of the TGF-β pathway is further supported by the upregulation of AP-1 (Jun-Fos) ^[@ref-59]^, as observed here during early anastasis. The up-regulation of the TGF-β pathway can also promote the expression of murine double minute 2 (Mdm2) ^[@ref-63],\ [@ref-64]^, an inhibitor of p53 that is also up-regulated during early anastasis ^[@ref-30]^. As p53 plays a critical role in regulating apoptosis and DNA repair ^[@ref-65],\ [@ref-66]^, the expression of Mdm2 could not only promote cell survival by inhibiting p53-mediated cell death, but also cause mutations as we have observed in the cells after anastasis ^[@ref-30]^. Expression of Mdm2 can also activate XIAP ^[@ref-67]^, which inhibits caspases 3, 7 and 9 ^[@ref-68]--\ [@ref-73]^, and therefore, could promote anastasis by suppressing the caspase-mediated cell destruction process. Up-regulation of anti-apoptotic BCL2 protein (Bag3) and heat shock proteins (Hsps) during anastasis can also neutralize pro-apoptotic proteins to promote cell recovery ^[@ref-26],\ [@ref-74],\ [@ref-75]^. Expression of Hmox1, which encodes heme oxygenase ^[@ref-76]^, could protect dying cells from free radicals that are generated during apoptosis. Notably, the expression of Bbc3, a pro-apoptotic BH3-only gene to encode PUMA (p53 upregulated modulator of apoptosis) ^[@ref-77],\ [@ref-78]^, peaks at anastasis (R3-R6), suggesting the sign of anastasis vs apoptosis in the recovering cells during the early stage of the cell recovery process.

![Interaction network of the up-regulated genes during anastasis.\
The 33 up-regulated genes during anastasis were selected for analysis using GeneMANIA.](f1000research-6-11669-g0004){#f5}

To reverse apoptosis, the recovering cells need to remove or recycle the destroyed cellular components, such as the toxic or damaged proteins that are cleaved by caspases, and dysfunctional organelles like the permeabilized mitochondria. Autophagy could contribute to anastasis, as the recovering cells display up-regulation of Atg12 ( [Figure 3B](#f3){ref-type="fig"}, [Table 2](#T2){ref-type="table"}), which is important to the formation of autophagosome to engulf the materials that are then transported to lysosomes or vacuoles for degradation ^[@ref-79]--\ [@ref-82]^. Sqstm1, which encodes sequestosome 1 ^[@ref-83]--\ [@ref-85]^ and is up-regulated at R6, could play important role in mediating autophagy and DNA damage response during anastasis. In fact, recently studies reveal that autophagy can be activated by the DNA damage response, and play a role in maintaining the nuclear and mitochondrial genomic integrity through DNA repair and removal of micronuclei and damaged nuclear parts ^[@ref-86],\ [@ref-87]^. This could suppress mutagenesis and oncogenic transformation to occur in the cells that reverse apoptosis as we have observed after DNA damage ^[@ref-30],\ [@ref-31]^. Autophagy is also implicated in the exosome secretory pathway ^[@ref-88]--\ [@ref-90]^, which could allow rapid clearance of damaged or toxic materials during anastasis through exosomes. Interestingly, our microarray data shows that the recovering cells display up-regulation of potent angiogenic factors such as Vegfa and Angptl4 ( [Figure 3A and B](#f3){ref-type="fig"}, [Table 1](#T1){ref-type="table"} and [Table 2](#T2){ref-type="table"}), which promote vascular permeability and angiogenesis ^[@ref-91]--\ [@ref-94]^. This could facilitate anastasis by supplying nutrient and clearing waste products. However, this could also enhance tumour recurrence, progression and metastasis ^[@ref-95]^, when anastasis occurs in cancer cells between cycles of cancer therapy. In fact, our data also reveals the up-regulation of genes involved in cell migration during anastasis ^[@ref-30]^, such as Mmp 9, 10 and 13 ( [Figure 3B](#f3){ref-type="fig"}, [Table 2](#T2){ref-type="table"}) that encode matrix metalloproteinases ^[@ref-96]--\ [@ref-99]^. This could be a stress-inducible response that promotes cell migration, like what we have observed in HeLa cells after anastasis ( [Supplementary Figure 4](#SM1){ref-type="other"}) ^[@ref-31]^, which might contribute to wound healing after tissue injury, or metastasis during cancer recurrence ^[@ref-100],\ [@ref-101]^.

Change in expression of histone proteins contributes to histone modification, which plays critical role in transcription, DNA replication and repairing ^[@ref-102]--\ [@ref-106]^. At the late stage of anastasis (R6), various histone genes display significant changes in expression ( [Table 2](#T2){ref-type="table"}, [Table 3](#T3){ref-type="table"}), suggesting potential connection between histone modification and reversal of apoptosis. Interestingly, significant number of histone genes are down-regulated during anastasis ( [Table 3](#T3){ref-type="table"}). Recent study reported histone degradation in response to DNA damage, and that is important for DNA repairing ^[@ref-107]^. As dying cells can reverse apoptosis after DNA damage ^[@ref-30],\ [@ref-31]^, reduction of histone gene expression could represent the DNA damage response during anastasis.

Arresting cell cycle during anastasis is important as it can allow damaged cells to be repaired before they restore proliferation. This hypothesis is supported by our microarray data that reveals up-regulation of genes that suppress cell cycle ( [Figure 3A--C](#f3){ref-type="fig"}). For example, B-cell translocation gene 1 (Btg1) is an anti-proliferative gene ^[@ref-108],\ [@ref-109]^, which is up-regulated during the early anastasis (R3). At later stage of anastasis (R6), other cell cycle inhibitors express, including Cdkn1a which encodes p21 that induces cell cycle arrest and senescence ^[@ref-110]--\ [@ref-112]^, and also Trp53inp1 which encodes tumor protein p53-inducible nuclear protein 1 that can arrest cell cycle independent to p53 expression ^[@ref-113]^. These suggest that cell cycle is suppressed by multiple pathways during anastasis.

We also identified genes that are up-regulated both during apoptosis and anastasis, such as Gadd45g, and Rnu6 ( [Figure 3C](#f3){ref-type="fig"}, [Table 4](#T4){ref-type="table"}). Gadd45g functions in growth arrest and DNA repair ^[@ref-114],\ [@ref-115]^, and therefore, could be the cytoprotective mechanism that preserves DNA in the dying cells during cell death induction (R0), and promotes the injured cells to repair when the environment is improved (R3 and R6). Rnu6 encodes U6 small nuclear RNA, which is important for splicing of a mammalian pre-mRNA ^[@ref-116]--\ [@ref-119]^. Upregulation of Rnu6 from R0 to R6 suggests that post-transcriptional regulation could be involved during apoptosis and anastasis. In fact, translational regulation also contributes to anastasis. For example, caspase-3, PARP and ICAD are cleaved in dying cells during apoptosis, and the non-cleaved form of corresponding proteins restores after anastasis ( [Figure 1B](#f1){ref-type="fig"}). Interestingly, the mRNA level of caspase-3, PARP and ICAD did not show significant increase during and after anastasis (see Data availability). This suggests the contribution of translational regulation during anastasis.

Our study provides new insights into the mechanisms and consequences of anastasis ( [Figure 6](#f6){ref-type="fig"}). Researchers can analyse our microarray data to further identify the hallmarks of anastasis, understand its role, elucidate molecular mechanisms that reverse apoptosis, and develop therapeutic strategies by controlling anastasis. To identify the genes that display specific change on a transcriptional level, software such as Spotfire can be used to view the gene expression pattern at different time points during the reversal of apoptosis ^[@ref-54]^. To study the molecular mechanism of anastasis, Ingenuity Pathway Analysis can be used to create mechanistic hypotheses according to the transcriptional profile ^[@ref-120]^. To identify drugs that modulate anastasis, Connectivity Map can be used to identify small molecules that promote or suppress anastasis based on its gene expression signature ^[@ref-121],\ [@ref-122]^. Anastasis could be a cell survival phenomenon mediated by multiple pathways ^[@ref-29]--\ [@ref-31],\ [@ref-33]^, so by comparing the gene expression profiles, researchers can study its potential connection to other cellular processes, such as anti-apoptotic pathways, autophagy, and stress-inducible responses ^[@ref-82],\ [@ref-123]--\ [@ref-127]^. By searching the molecular signature of anastasis, researchers can study its potential contribution to physiological and pathological conditions, such as recovery from heart failure, wound healing, mutagenesis, tumour evolution, cancer recurrence and metastasis ^[@ref-45],\ [@ref-100],\ [@ref-101],\ [@ref-128]^. Further data analysis will stimulate the generation of hypotheses for future studies involving anastasis. As our understanding of anastasis mechanism expands, it will uncover its potential impacts on physiology and pathology, and offer exciting new therapeutic opportunities to intractable diseases by mediating cell death and survival ( [Figure 7](#f7){ref-type="fig"}).

![Up-regulation of genes and potential corresponding pathways during reversal of apoptosis.](f1000research-6-11669-g0005){#f6}

![Potential consequences of anastasis.](f1000research-6-11669-g0006){#f7}
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Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication). <http://creativecommons.org/publicdomain/zero/1.0/>

*Figshare*: Raw data for Tang *et al.*, 2016 "Molecular signature of anastasis for reversal of apoptosis" doi: [10.6084/m9.figshare.4502732](http://dx.doi.org/10.6084/m9.figshare.4502732)

<http://dx.doi.org/10.6084/m9.figshare.4502732>

We thank J. Marie Hardwick for valuable advice to this work, and the Johns Hopkins Deep Sequencing and Microarray Core Facility for data analysis. Ho Lam Tang is a Shurl and Kay Curci Foundation Fellow of the Life Sciences Research Foundation.

Supplementary material {#SM1}
======================

**Supplementary Figure 1: Technical validation of microarray data.** The three biological replicate samples of microarray data were shown to cluster together by using principal component analysis (PCA).

**Supplementary Figure 2: Genes display unique expression patterns at each timepoint.** Output of all genes analysed by Spotfire (K cluster, also see Data availability).

**Supplementary Figure 3. Uncropped agarose gel images.** RT-PCR gel analysis of changes in mRNA levels of ANGPTL4, ATF3, ATG12, CDKN1A, FOS, HSPA1B, JUN, MDM2, MMP10 and SOX9 on untreated (Lane 1: Ctrl), treated (Lane 2: R0, 4.5% ethanol for 5 hours), and the treated cells that were then washed and incubated in fresh medium for 1 hour (Lane 3: R1), 2 hours (Lane 4: R2), 3 hours (Lane 5: R3), 4 hours (Lane 6: R4), 6 hours (Lane 7: R6), 9 hours (Lane 8: R9), 12 hours (Lane 9: R12), and 24 hours (Lane 10: R24). GUSB serves as housekeeping gene. Lane M is loaded with 25 bp DNA Ladder (Invitrogen). Sequences of primer sets for detecting targeted genes are available in [Table 5](#T5){ref-type="table"}.

**Supplementary Figure 4: Increase in mobility of HeLa cells after reversal of ethanol-induced apoptosis.** Time-lapse live-cell fluorescence microscopy of HeLa cells before, during, and after exposure to the apoptotic stimulus, ethanol. The same cells before ethanol induction (Untreated, *i*), induced with 5% ethanol in culture medium for 55 minutes (Induced, *ii* to *iv*), and then washed and further cultured with fresh medium (Washed, *v* to *xx*). Green, white and yellow lines indicate the footprints of the corresponding same cells that reversed apoptosis throughout the experiment with time. Cells without displayed hallmarks of apoptosis at late stage, such as cell shrinkage and nucleus condensation (without track), had lower mobility than the tracked cells. Merged images, mitochondria (red) and nuclei (blue) were visualized by fluorescence, and cell morphology by differential interference contrast (DIC) microscopy. Time presented as hour:minute. Scale bar, 10 μm. Adopted images reprinted with permission ^[@ref-129]^.

Click here for additional data file..
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Version 2

The data presented build on the authors' earlier studies of reversal of apoptosis. They provide useful information documenting changes in gene expression following 5 hours of exposure to ethanol, an apoptotic stimulus to primary mouse liver cells. The findings only make sense when taken in combination with the authors previous work, which provides a compelling case that the recovery from apoptosis in indeed occurring, and the manuscript documents some of this by reprinting figure panels from an earlier publication in Figure 1.  

My only minor comment is that, at least in some cells such as neurons, cleavage of caspase-3 can be a regulatory signal that does not herald cell death, but may influence biological processes such as synaptic function.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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The authors sincerely responded to my comment with deep consideration. Therefore I have no objection to this article being indexed.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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The manuscript by Tang et al. was focused on the elucidation of the molecular mechanisms of an important phenomenon, anastasis, through time-course expression profiling. Anastasis was recently discovered and has not been fully studied yet. It\'s molecular basis remains to be uncovered. The study provided useful information to better understand this underexplored process. Overall, the experiment was well designed. The time course experiment included six time points, untreated samples as the control, toxin-induced apoptosis, and four time points after removal of toxin. Three biological replicates were performed at each time point. Figure 1 illustrated the experimental design very well. The biological interpretation of microarray results is reasonable. The reviewer has no major concerns. However, several minor changes are needed, especially for the presentation of figures, which could be improved.

First, no multiple test correction was mentioned in the microarray analysis section. It was described that the p-value less than 0.05 was used to declare statistical significance. The reviewer would suggest the authors confirm that. A false discovery rate (FDR) method is needed for multiple test correction.

Second, the PCA result from Figure 2A showed that three biological replicates were closely clustered, which showed a good repeatability. However, the goal of PCA is not just check the repeatability of three replicates of each group (time point). PCA can be also used to examine the relationship among groups. My recommendation is that the authors provide more description for the PCA result. In addition, in Figure 2A, the percentage of PC2 explaining total variation was masked. But based on the value of PC3, it should be greater than 5.89%. Given the high value of PC1, I would suggest plotting a two dimension PCA plot to display the result or re-plotting this three-dimension plot.

Third, it would be useful to list the number of significant differential expression for each comparison. And I guess the clustering result in Figure 3 presented all significant genes.

Figure 4 showed some interesting result about gene interactions. I did not see enough description about this figure in the main text.

Editorial comments:

In the Abstract, "whole genome" can be replaced by "genome-wide".

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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This study unravels the gene regulatory network that seems to be involved in the process of anastasis. It is interesting that the authors found various genes that appear to participate in ethanol-induced anastasis, suggesting that the dynamic reconstitution of gene regulatory networks might be a prerequisite for rescuing cells from the brink of cell death. Overall, this work is worth being indexed. However, I would like to see the following points in the research addressed, before approval: Anastasis is a developing concept rather than an established one. It would be better to show the expression dynamics of caspase-3, PARP, and ICAD at all analyzed time points (Cont, R0, R3, R6, R24, and R48). In addition, why don\'t the authors show apoptotic DNA fragmentation to make sure that all the analyzed cells in the anastasis stage definitely underwent apoptosis?I may have missed noting this, but there is no statistical analysis of the gene expression changes observed in the microarray data. In Fig. 2B, the expression levels of several genes seem different in the same time point replicates. It would be better to show the genes that were induced or suppressed during anastasis, along with the statistical significance of the differences.Given the importance of understanding the mechanism of anastasis, it would be better to verify the data obtained from microarray analysis, by using quantitative PCR or Western blotting.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Tang
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We thank for the enthusiasm and valuable input from the reviewer, and have made the following changes: We have included the Western blot data (Figure 1B), which shows that caspase-3, PARP and ICAD were cleaved during apoptosis, but then recovered to their original level at 24 hours after removal of the cell death stimulus. Interestingly, our microarray data shows that their level of mRNA remained no significant change at all time points (3, 6, 24 and 48 hours) after removal of the cell death stimulus, compared with the untreated (control) cells (data available at figshare, please see *Data availability* in the manuscript), suggesting the recovery of corresponding proteins is contributed by the regulation of translation during and after anastasis. The related data and discussion are included in our revised manuscript.Our earlier studies using time-lapse live cell microscopy and comic assay demonstrated that the current apoptotic induction (4.5% ethanol, 5 hours) can trigger DNA damage. After removal of the stimulus, major of the dying cells can recover. Interestingly, some cells that reversed apoptosis display chromosomal abnormality and oncogenic transformation, indicating reversibility of apoptosis after DNA damage. In our current study, we further found significant reduction of mRNA level of multiple histone genes during anastasis. Notably, cellular levels of histones reduce in response to DNA damage, as to enhance DNA repairing. Therefore, reduction of expression of histones during anastasis could be a sign of cells that recover from DNA damage after apoptosis. We have included supplementary data with corresponding p-value for statistical significance of fold change for all of the 3 biological replicants of each gene (see Data availability). The software for the microarray data analysis is mentioned at the "Materials and methods" section.We have verified our data by RT-PCR in human liver cancer HepG2 cell line, and included the data in the new Figure 4.
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